K-757 and K-833 BID + K-757 and K-833 QD for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Dec 2023: Trial started, NCT06305351
  2. 12 Mar 2024: Trial registered, NCT06305351

The trials

NCT06305351: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

State
Completed
Phase
Phase 1
People
25 taking part
Started
7 Dec 2023
Primary completion
15 May 2024
Arms
K-757 and K-833 combination
Results
None posted
  1. 7 Dec 2023: Trial started
  2. 12 Mar 2024: Trial registered
  3. 21 Jun 2024: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.